Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington

Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington

Submitted by admin on February 27, 2019 - 7:21pm
Source: 
Xconomy
News Tags: 
Bristol-Myers Squibb
Celgene
M&A
Wellington
Headline: 
Bristol-Myers’ $74B Celgene Buyout Faces Opposition from Wellington
snippet: 

Bristol-Myers Squibb’s $74 billion agreement to acquire Celgene is opposed by the New York pharmaceutical company’s largest institutional investor.

Do Not Allow Advertisers to Use My Personal information